Genea Biocells

Human Stem Cell Model of Muscular Dystrophy (FSHD) – qPCR

Chemical Genomics

Our team at Genea Biocells was one of the first to systematically use high-throughput screening to modulate pluripotency maintenance and differentiation of stem cells. We developed a monolayer culture method for human pluripotent stem cells in 2008 to enable efficient high-content imaging – our primary technology for drug screening, optimization of culture processes and aspects of quality control testing. Our medicinal chemistry platform...

Stem Cell Bank

Genea Biocells developed one of the world’s largest banks of diverse, ethically derived, NIH approved human embryonic stem cell lines. Our sister company, Genea Fertility, is a world leading IVF clinic in Australia that gives patients the option to donate access and disease-affected embryos to research and stem cell derivation. Our bank now contains: >150 lines many of which are approved by the NIH and the UK-SCB Disease affected cell lines...